Feasibility of the Multiple Sclerosis Performance Test in Participants With Multiple Sclerosis

NCT03926637 · clinicaltrials.gov ↗
TERMINATED
Status
3073
Enrollment
INDUSTRY
Sponsor class

Stopped Biogen will stop any further development of the MSPT. The data collected thus far in the MSPT Feasibility Study allow us to answer the primary study objectives that are associated with assessing the feasibility of the MSPT in a clinical care setting.

Conditions

Interventions

Sponsor

Biogen